Vaginal Disease
12
0
0
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (12)
Feasibility of an Oral Intervention for Sexual Health in Transgender Men
Integrated Genetic and Functional Analysis of the Influence of Menstrual Hygiene Products on Female Health
Efficacy and Safety of a Hyaluronic Acid-Based Vaginal Moisturizer Medical Device to Ease Symptoms of Vaginal Dryness
Omegia Softgel Clinical Research Program
Study of the Vaginal Microbiota in Women Under Fertile Age
Safety, Tolerability, and Acceptability Study of Intravaginal Administration of LABTHERA-001 Capsules in Healthy Women
Evaluation of Mucogyne® Ovule in Vulvovaginal Dryness Management in Women Treated by Brachytherapy and/or Radiotherapy for Endometrial or Cervical Cancer.
Post Marketing Follow Up Study To Evaluate Performance Safety Quality of Menopausal Transition Women Treated With Ainara
Open Non-Comparative Clinical Trial Study To Evaluate The Performance And Safety Of Ainara®
Evaluation of Gynecological Acceptability of 3 Health Care Products
Clinical Trial Study To Evaluate The Performance And Safety Of Ainara®
Hyaluronic Acid and Vaginal Distress